Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Glucose-regulated protein-78 (GRP78) is identified as a molecular target on metastatic tumors.
• Antibody repertoire analysis from cancer patients revealed GRP78's relevance.

Purpose of the Study:

• To design and evaluate a ligand-receptor system targeting GRP78 expressed on tumor cell membranes.
• To assess the potential of GRP78-targeting peptides for cancer therapy.

Main Methods:

• Designing a ligand-receptor system utilizing GRP78.
• In vivo and ex vivo targeting of tumor cells using GRP78 binding peptide motifs.
• Evaluating synthetic chimeric peptides for tumor suppression in mouse models.

Main Results:

• GRP78 binding peptide motifs demonstrated specific targeting of tumor cells in vivo and ex vivo.
• Synthetic chimeric peptides incorporating GRP78 binding motifs suppressed tumor growth in prostate and breast cancer models.
• Preclinical data validate GRP78 as a functional cell surface target.

Conclusions:

• GRP78 is a validated molecular target on the tumor cell surface.
• Peptide-based targeting of GRP78 shows promise for clinical cancer applications.
• Further translation into clinical settings is warranted based on these findings.